Assembled from the company's filings and exchange data as of today. Download PDF renders this page on the server; the narrative sections arrive with the Nexa composer.
Dossier · Chemkart India Limited · 28 October 2026Page 1 of 3
Company Dossier
MarketPing Research · factual · no rating expressed
Chemkart India Limited BSE: 544442
Fast Moving Consumer Goods › Fast Moving Consumer Goods › Food Products › Other Food Products
Chemkart India Limited
StateQ4 FY26 filed
Last close · 27 Oct 2026₹257.00
Market cap₹0.3k cr
TTM P/E · P/B · EV/EBITDA— · — · —
Distributes and trades nutraceutical and food ingredients in India, with FY26 consolidated revenue of Rs 214.83 crore, up 5.7% year-on-year supported by 7.1% volume growth. Sales are business-to-business to nutraceutical, food and supplement companies, with 15 new key customers added recently and 20 R&D projects in the pipeline. The wholly-owned subsidiary Easy Raw Materials Pvt Ltd (ERMPL) trades pharma products and nutritional supplements, while another wholly-owned subsidiary, Vinstar Biotech, develops in-house value-added ingredients and recorded Rs 223.43 lakh turnover in FY25-26. The group is moving from pure distribution into contract manufacturing through a CDMO facility under construction at JNPA SEZ, Navi Mumbai, with Rs 6,524 lakh in advance and open orders providing near-term visibility. Q1 FY27 revenue reached Rs 99.60 crore, roughly half of the previous full year. Listed on BSE SME in July 2025 via an IPO of Rs 6,448 lakh, with Rs 34.68 crore of net proceeds earmarked for the manufacturing facility, of which Rs 4.57 crore has been deployed. FY26 EBITDA margin compressed to 13.1% from 16.2% on US tariff uncertainties and export headwinds. AR · MarketPing reader · 2026-08-03
Revenue streams, as the annual report describes them. Nutraceutical and food ingredient distribution, Pharma products and nutritional supplements, In-house value-added ingredients, CDMO contract manufacturing. Asset-light nutraceutical distribution and trading, transitioning into integrated contract manufacturing
What a broker report prints here — the analyst's thesis. This dossier prints the filed record instead; the narrative read of the latest results, the guidance ledger and the earnings-call summary are the composer's sections (INSTITUTIONAL-PLAN.md M3) and are not yet produced.
Exhibit 1: Financial summary, FY26–FY26 (all audited; no estimate years)
₹ crore · consolidated
FY26
Revenue
215
EBITDA (ex other income)
—
margin %
—
Owners' profit
—
EPS, as reported (₹)
17.26
ROE % · ROCE %
— · 21.8
Debt / equity (x)
—
Cash from operations
(3)
Capex
(5)
Source: SEBI results XBRL as filed with BSE/NSE; EBITDA excludes other income.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · Chemkart India Limited · 28 October 2026Page 2 of 3
Exhibit 2: Quarterly performance, last 2 quarters
₹ crore
Q2 FY26
Q4 FY26
Revenue
103
112
Profit before tax
14
13
Net profit
—
—
EPS (₹)
9.50
7.86
Source: quarterly results as filed; the balance sheet is filed half-yearly and is not repeated here.
Exhibit 3: Peers — basic industry group, by market cap
Company
M.cap ₹ cr
P/E
P/B
EV/EBITDA
ROE %
ROCE %
Rev CAGR 5y %
EBITDA m. %
EID PARRY INDIA LTD
11,045
23.8
0.74
3.8
9.3
13.1
15.7
8.7
MANORAMA INDUSTRIES LTD
10,957
42.7
16.06
30.4
33.0
42.4
—
30.3
ORKLA INDIA LIMITED
7,178
24.4
2.61
16.1
10.4
13.1
—
19.9
KRISHIVAL FOODS LIMITED
816
34.4
4.08
21.1
11.1
13.1
—
13.0
APIS INDIA LTD.
743
2.9
3.74
19.3
12.7
15.5
7.4
11.9
Pajson Agro India Limited
675
51.8
—
—
—
24.0
—
—
Chemkart India Limited ◆
311
14.8
—
—
—
20.7
—
—
MEGASTAR FOODS LIMITED
288
29.1
2.80
11.6
9.0
7.5
26.4
5.8
Source: exchange data and filed statements via the screener; multiples at current prices.
Exhibit 4: Where the company sits in its group
Metric
Company
Group median
Rank
Better than
P/E (TTM)
14.8
24.1
11 of 26
60%
ROCE
20.7
12.6
6 of 30
83%
Market cap
311
107
7 of 29
79%
Source: MarketPing peer ranks; a rank is a measurement, not a view.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · Chemkart India Limited · 28 October 2026Page 3 of 3
Exhibit 5: Filings of the last 90 days, with the measured price reaction
Date · filing
Category
Importance
Next day %
5-day %
27 Oct 2026 · Chemkart invests Rs 97.90 lakh in wholly owned subsidiary
strategic transactions
low
—
—
18 Oct 2026 · Board meeting on Oct 30 2026 to consider H1 FY26 unaudited results
results
low
—
—
14 Oct 2026 · Chemarkt India Updates CIN To Reflect BSE Listing
compliance
minimal
—
—
10 Oct 2026 · Routine compliance filing on share dematerialisation for Q2 FY27
compliance
minimal
—
—
26 Sept 2026 · Trading window closure from 1 Oct 2026 ahead of H1 results
compliance
minimal
—
—
21 Sept 2026 · All 4 resolutions passed unanimously at 7th AGM
board shareholder meetings
medium
—
—
19 Sept 2026 · Chemkart India 7th AGM Held - 4 Items Transacted
board shareholder meetings
low
—
—
16 Sept 2026 · Chemkart invests Rs 1.30 Cr in wholly-owned subsidiary via rights issue
strategic transactions
medium
—
—
10 Sept 2026 · CFO change at Chemkart India: Dalawai resigns, Asim Siddiqui appointed
management changes
high
—
—
10 Sept 2026 · CFO resigns, new CFO appointed at Chemkart India
management changes
high
—
—
Source: exchange announcements; each reaction is measured from the close before the filing. Next day = the close one session after the reaction day (the first session that could trade the filing).
How to read this document
Where a broker report shows
This document shows
Why
A rating (BUY / ADD / REDUCE / SELL)
A state: the latest filed quarter and the measured reactions
an event is a fact; a rating is an opinion that requires SEBI RA registration
A target price and upside
The current price and the multiples against the group
a target is a forecast; a multiple is a measurement
Estimate years marked E
More audited years; no estimates
MarketPing publishes no forecasts — your own model lives on the Models page
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
